Neuroendocrine neoplasms in the breast oncology field: dilemmas of nature and morphology

Tomonori Kawasaki; Tomoaki Tashima; Atsushi Enomoto; Jiro Ichikawa; Hirokazu Nagai; Chisako Muramatsu; Yasuhiro Nakamura; Kyoichi Kaira

doi:10.3389/fendo.2023.1216424

Neuroendocrine neoplasms in the breast oncology field: dilemmas of nature and morphology

Front Endocrinol (Lausanne). 2023 Nov 1:14:1216424. doi: 10.3389/fendo.2023.1216424. eCollection 2023.

Authors

Tomonori Kawasaki^{1

2

3

4

5}, Tomoaki Tashima², Atsushi Enomoto³, Jiro Ichikawa⁴, Hirokazu Nagai⁵, Chisako Muramatsu⁶, Yasuhiro Nakamura², Kyoichi Kaira²

Affiliations

¹ Department of Pathology, Saitama Medical University International Medical Center, Hidaka, Japan.
² Comprehensive Cancer Center, Saitama Medical University International Medical Center, Hidaka, Japan.
³ Department of Pathology, Nagoya University Graduate School of Medicine, Aichi, Japan.
⁴ Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
⁵ Clinical Research Center, Nagoya Medical Center, Aichi, Japan.
⁶ Faculty of Data Science, Shiga University, Hikone, Japan.

No abstract available

Keywords: breast; diagnosis; immunohistochemistry; insulinoma-associated protein 1; neuroendocrine neoplasm; neuroendocrine tumor; treatment.

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinoma, Neuroendocrine*
Humans
Neuroendocrine Tumors* / epidemiology
Neuroendocrine Tumors* / therapy

Grants and funding

TK is supported by Grants-in-Aid for Scientific Research (Nos. 21K06910 and 23K11869) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, National Hospital Organization (NHO) Grant (H29-NHO-01), and Joint Research Support Grant based on the Comprehensive Agreement between Saitama University and Saitama Medical University (21-J-14, 22-J-01 and 23-J-08).